A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Levorphanol
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Lapatinib.
Levorphanol
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Lapatinib.
Levorphanol
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Lapatinib.
Levorphanol
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Lapatinib.
Temozolomide
Oliceridine
The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Oliceridine.
Temozolomide
Givosiran
The serum concentration of Lisdexamfetamine can be increased when it is combined with Givosiran.
Temozolomide
Lasmiditan
The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Lasmiditan.
Temozolomide
Dronedarone
The metabolism of Dronedarone can be decreased when combined with Lisdexamfetamine.
Temozolomide
Hydrocodone
The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Lisdexamfetamine.
Temozolomide
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Lisdexamfetamine.
Temozolomide
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Lisdexamfetamine.
Temozolomide
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Lisdexamfetamine.
Temozolomide
Thyrotropin
The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Thyrotropin.
Temozolomide
Benzylthiouracil
The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Benzylthiouracil.
Temozolomide
Elcatonin
The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Elcatonin.
Temozolomide
Methylthiouracil
The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Methylthiouracil.
Temozolomide
3,5-diiodothyropropionic acid
The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with 3,5-diiodothyropropionic acid.
Temozolomide
Protirelin
The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Protirelin.
Temozolomide
Potassium perchlorate
The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Potassium perchlorate.
Temozolomide
Thyroid, porcine
The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Thyroid, porcine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3